6,800 Shares in National Health Investors Inc (NYSE:NHI) Purchased by ARP Americas LP

ARP Americas LP purchased a new position in shares of National Health Investors Inc (NYSE:NHI) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 6,800 shares of the real estate investment trust’s stock, valued at approximately $413,000.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Raymond James & Associates boosted its stake in shares of National Health Investors by 10.0% during the 2nd quarter. Raymond James & Associates now owns 81,132 shares of the real estate investment trust’s stock worth $4,926,000 after purchasing an additional 7,406 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of National Health Investors by 61.4% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 29,487 shares of the real estate investment trust’s stock worth $1,790,000 after purchasing an additional 11,220 shares during the period. Nisa Investment Advisors LLC boosted its stake in shares of National Health Investors by 29.6% during the 2nd quarter. Nisa Investment Advisors LLC now owns 21,445 shares of the real estate investment trust’s stock worth $1,302,000 after purchasing an additional 4,897 shares during the period. Sumitomo Mitsui Trust Holdings Inc. boosted its position in National Health Investors by 7.4% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 96,231 shares of the real estate investment trust’s stock valued at $5,843,000 after buying an additional 6,622 shares during the period. Finally, Dupont Capital Management Corp purchased a new stake in National Health Investors in the 2nd quarter valued at about $737,000. 68.92% of the stock is owned by hedge funds and other institutional investors.

Shares of NYSE:NHI traded down $1.54 during trading hours on Friday, hitting $62.00. The company’s stock had a trading volume of 387,638 shares, compared to its average volume of 260,759. National Health Investors Inc has a 52 week low of $31.37 and a 52 week high of $91.12. The company has a debt-to-equity ratio of 1.03, a current ratio of 12.05 and a quick ratio of 12.05. The company has a market capitalization of $2.77 billion, a price-to-earnings ratio of 14.73 and a beta of 0.84. The firm’s fifty day moving average price is $59.57 and its 200 day moving average price is $63.97.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Monday, May 11th. The real estate investment trust reported $1.37 EPS for the quarter, missing the consensus estimate of $1.40 by ($0.03). The business had revenue of $83.08 million during the quarter, compared to the consensus estimate of $80.77 million. National Health Investors had a net margin of 57.16% and a return on equity of 12.62%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.31 EPS. On average, equities research analysts predict that National Health Investors Inc will post 5.61 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be paid a dividend of $1.102 per share. The ex-dividend date is Monday, June 29th. This represents a $4.41 annualized dividend and a dividend yield of 7.11%. National Health Investors’s dividend payout ratio (DPR) is presently 80.18%.

Several equities research analysts have issued reports on NHI shares. JMP Securities started coverage on shares of National Health Investors in a research report on Monday, June 8th. They issued a “market perform” rating for the company. SunTrust Banks boosted their price objective on shares of National Health Investors from $61.00 to $64.00 and gave the company a “hold” rating in a research report on Wednesday, June 24th. Mizuho cut shares of National Health Investors from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $60.00 to $55.00 in a research report on Friday, May 22nd. KeyCorp lowered their price objective on shares of National Health Investors from $43.00 to $40.00 and set an “underweight” rating for the company in a research report on Thursday, May 14th. Finally, Wells Fargo & Co boosted their price objective on shares of National Health Investors from $54.00 to $66.00 and gave the company an “equal weight” rating in a research report on Wednesday, June 17th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $70.14.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Article: Momentum Investing

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors Inc (NYSE:NHI).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.